论文部分内容阅读
白细胞减少症日渐增多,而目前临床上所用的升白药疗效不稳定,特别是远期疗效更差.本文报告作者在动物研究的基础上,用所研制的王浆制剂对白细胞减少症所进行的临床研究.指出无论住院或门诊治疗,均有一定疗效,特别是远期疗效较好,值得重视.文中还讨论了疗效巩固与否和疗程长短的关系,疗效与剂型、给药途径(舌下含服)的关系,及其作用机制等问题.同时结合过去工作,提出可以用此王浆制剂,作为预防某些理化因素导致白胞减少的预防药的设想.
Leukopenia is increasing day by day, but the clinical efficacy of the drug is not stable, especially the long-term efficacy is even worse. This article reports the author’s clinical study of the use of the royal jelly preparation on leukopenia in the clinical Research indicates that both hospitalization and outpatient treatment have certain curative effect, especially long-term curative effect is good, worthy of attention. The paper also discusses the relationship between curative effect and duration of treatment, curative effect and dosage form, administration route (under the tongue The relationship between the service and its mechanism of action, etc. In conjunction with past work, it is proposed that this royal jelly preparation can be used as a preventive medicine to prevent certain physical and chemical factors from causing the reduction of the number of white blood cells.